Back to the directory
Felix Biotechnology
We’re creating programmable therapies
- Founded
- 2019
- Status
- Inactive
- Stage
- Early
- Team size
- 6
- Location
- San Francisco, CA, USA
- Category
- Biotech & Drug Discovery
- Sector
- Drug Discovery and Delivery
About Felix Biotechnology
We are building the first end-to-end digital viral design platform to protect the world against the coming threat of antimicrobial resistance.
BiotechGenomicsTherapeutics
Federal research funding
3 NIH awards totalling $798,835, FY2022 to FY2023.
- Developing generalized engineering tools to create enhanced phage therapy for the clinic and commercialization
- Microfluidics Platform for Rapid, High-throughput Screening of Therapeutic Bacteriophages Based on Patient Bac
Source: NIH RePORTER.
Company data compiled and maintained by Healthcare Discovery.
